CRISPR

Beam hits hemoglobin goal in first base editing clinical data, reports death tied to conditioning drug
Fierce Biotech
Tue, 11/5/24 - 10:05 am
Beam Therapeutics
clinical trials
sickle cell disease
CRISPR
base editing
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks in phase 2
Fierce Biotech
Thu, 10/24/24 - 09:58 am
Intellia Therapeutics
CRISPR
HAE
NTLA-2002
Editas, changing course again, looks to partner lead CRISPR therapy
BioPharma Dive
Tue, 10/22/24 - 11:45 am
Editas Medicine
gene editing
CRISPR
reni-cel
sickle cell disease
beta thalassemia
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
Fierce Pharma
Tue, 09/24/24 - 09:51 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Lonza
Casgevy
Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits
Reuters
Tue, 08/13/24 - 11:01 pm
Illumina
Medtech
Broad Institute
CRISPR
gene sequencing
Vertex sues U.S. government over access to fertility support services for Casgevy patients
Stat
Mon, 07/15/24 - 11:13 pm
Vertex Pharmaceuticals
Fertility
CRISPR
Casgevy
First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
BioPharma Dive
Wed, 06/26/24 - 10:00 am
Intellia Therapeutics
CRISPR
gene editing
transthyretin amyloidosis
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive
Thu, 04/25/24 - 11:31 am
Regeneron
Mammoth Biosciences
CRISPR
gene editing
Vertex Fails to Convince UK Watchdog of CRISPR Therapy Casgevy’s Value
BioSpace
Thu, 03/14/24 - 06:19 pm
Vertex Pharmaceuticals
UK
sickle cell disease
CRISPR
Casgevy
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
BioSpace
Wed, 03/13/24 - 10:39 am
Ricoh
ERS Genomics
gene editing
CRISPR
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia’s CRISPR drug could offer one-shot HAE treatment
Pharmaphorum
Thu, 02/1/24 - 11:26 am
Intellia Therapeutics
HAE
clinical trials
CRISPR
gene editing
NTLA-2002
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
CRISPR Therapeutics
gene editing
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
Gene editing startup Metagenomi files for an IPO
BioPharma Dive
Sun, 01/7/24 - 04:16 pm
Metagenomi
CRISPR
IPOs
gene editing
A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome
BioPharma Dive
Thu, 01/4/24 - 10:10 am
Moonwalk Biosciences
CRISPR
gene editing
funding
Feng Zhang
This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain
Pharma Voice
Tue, 12/19/23 - 10:29 am
Arbor Biotechnologies
gene editing
CRISPR
Bluebird’s Newly Approved SCD Gene Therapy Faces Rough Road with Hefty Price Tag, Boxed Warning
BioSpace
Mon, 12/11/23 - 11:20 am
Bluebird Bio
sickle cell disease
Lyfgenia
gene therapy
CRISPR
FDA approves bluebird's sickle cell disease gene therapy. Can Lyfgenia overcome CRISPR's halo?
Fierce Pharma
Sun, 12/10/23 - 11:15 pm
Bluebird Bio
sickle cell disease
FDA
CRISPR
Lyfgenia

Pages